Robert E. Gagnon insider trades: Opus Genetics (IRD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
51 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | IRD | ↓ Sell | 14,000 | $3.55 | $50K | Direct | Oct 27, 2026 (4d) |
| Sep 3, 2026 | IRD | ↓ Sell | 28,000 | $4.54 | $127K | Direct | Sep 8, 2026 (5d) |
| Dec 16, 2025 | VSTM | ↓ Sell | 283 | $9.14 | $3K | Direct | Dec 18, 2025 (2d) |
| Sep 16, 2025 | VSTM | ↓ Sell | 281 | $9.99 | $3K | Direct | Sep 18, 2025 (2d) |
| Jun 16, 2025 | VSTM | ↓ Sell | 284 | $5.65 | $2K | Direct | Jun 20, 2025 (4d) |
| Mar 17, 2025 | VSTM | ↓ Sell | 284 | $6.95 | $2K | Direct | Mar 19, 2025 (2d) |
| Dec 19, 2024 | VSTM | ↓ Sell | 415 | $4.49 | $2K | Direct | Dec 20, 2024 (1d) |
| Sep 19, 2024 | VSTM | ↓ Sell | 131 | $2.79 | $365 | Direct | Sep 20, 2024 (1d) |
| Sep 16, 2024 | VSTM | ↓ Sell | 287 | $2.80 | $804 | Direct | Sep 18, 2024 (2d) |
| Jun 20, 2024 | VSTM | ↓ Sell | 414 | $3.40 | $1K | Direct | Jun 20, 2024 (0d) |
| Mar 19, 2024 | VSTM | ↓ Sell | 413 | $10.61 | $4K | Direct | Mar 20, 2024 (1d) |
| Feb 6, 2024 | VSTM | ↓ Sell10b5-1 | 9,204 | $13.70 | $126K | Direct | Feb 7, 2024 (1d) |
| Jan 12, 2024 | VSTM | ↓ Sell10b5-1 | 9,204 | $10.95 | $101K | Direct | Jan 17, 2024 (5d) |
| Dec 19, 2023 | VSTM | ↓ Sell | 414 | $7.67 | $3K | Direct | Dec 20, 2023 (1d) |
| Sep 19, 2023 | VSTM | ↓ Sell | 408 | $9.89 | $4K | Direct | Sep 20, 2023 (1d) |
| Jun 20, 2023 | VSTM | ↓ Sell | 413 | $10.04 | $4K | Direct | Jun 21, 2023 (1d) |
| Mar 20, 2023 | VSTM | ↓ Sell | 5,318 | $0.41 | $2K | Direct | Mar 20, 2023 (0d) |
| Dec 19, 2022 | VSTM | ↓ Sell | 13,837 | $0.40 | $5K | Direct | Dec 20, 2022 (1d) |
| Sep 19, 2022 | VSTM | ↓ Sell | 1,348 | $1.13 | $2K | Direct | Sep 21, 2022 (2d) |
| Jun 21, 2022 | VSTM | ↓ Sell | 1,351 | $1.14 | $2K | Direct | Jun 22, 2022 (1d) |
| May 16, 2022 | VSTM | ↓ Sell | 16,627 | $1.03 | $17K | Direct | May 17, 2022 (1d) |
| Mar 21, 2022 | VSTM | ↓ Sell | 1,409 | $1.27 | $2K | Direct | Mar 23, 2022 (2d) |
| Jan 3, 2022 | VSTM | ↓ Sell | 19,612 | $2.05 | $40K | Direct | Jan 5, 2022 (2d) |
| Dec 20, 2021 | VSTM | ↓ Sell | 5,497 | $2.27 | $12K | Direct | Dec 22, 2021 (2d) |
| Aug 29, 2018 | HBIO | ↓ Sell | 8,889 | $5.77 | $51K | Direct | Aug 30, 2018 (1d) |
| Aug 7, 2018 | HBIO | ↓ Sell | 100,015 | $6.08 | $608K | Direct | Aug 9, 2018 (2d) |
| Jul 27, 2018 | HBIO | ↓ Sell | 62,514 | $5.54 | $346K | Direct | Jul 31, 2018 (4d) |
| Jul 24, 2018 | HBIO | ↓ Sell | 5,570 | $5.25 | $29K | Direct | Jul 26, 2018 (2d) |
| Jul 23, 2018 | HBIO | ↓ Sell | 2,565 | $5.25 | $13K | Direct | Jul 23, 2018 (0d) |
| Jul 13, 2018 | HBIO | ↓ Sell | 10,207 | $5.25 | $54K | Direct | Jul 16, 2018 (3d) |
| Jul 11, 2018 | HBIO | ↓ Sell | 169,200 | $5.26 | $890K | Direct | Jul 11, 2018 (0d) |
| Mar 7, 2018 | HBIO | ↓ Sell | 97,087 | $4.62 | $449K | Direct | Mar 12, 2018 (5d) |
| May 26, 2017 | HBIO | ↑ Buy | 1,000 | $2.33 | $2K | Direct | May 30, 2017 (4d) |
| Nov 3, 2016 | HBIO | ↑ Buy | 25,000 | $2.34 | $58K | Direct | Nov 3, 2016 (0d) |
| Nov 12, 2015 | HBIO | ↑ Buy | 1,500 | $2.93 | $4K | Direct | Nov 16, 2015 (4d) |
| Nov 9, 2015 | HBIO | ↑ Buy | 3,000 | $3.08 | $9K | Direct | Nov 9, 2015 (0d) |
| Jun 16, 2014 | HBIO | ↑ Buy | 5,000 | $3.85 | $19K | Direct | Jun 16, 2014 (0d) |
| Feb 29, 2012 | BIIB | ↓ Sell | 1,552 | $115.25 | $179K | Direct | Mar 1, 2012 (1d) |
| Feb 24, 2012 | BIIB | ↓ Sell | 1,054 | $115.53 | $122K | Direct | Feb 27, 2012 (3d) |
| Feb 14, 2012 | BIIB | ↓ Sell | 560 | $118.61 | $66K | Direct | Feb 16, 2012 (2d) |
| Dec 6, 2011 | BIIB | ↓ Sell | 795 | $112.31 | $89K | Direct | Dec 8, 2011 (2d) |
| Nov 9, 2011 | BIIB | ↓ Sell | 796 | $112.04 | $89K | Direct | Nov 14, 2011 (5d) |
| Oct 5, 2011 | BIIB | ↓ Sell | 252 | $97.66 | $25K | Direct | Oct 7, 2011 (2d) |
| Oct 3, 2011 | BIIB | ↓ Sell | 778 | $92.55 | $72K | Direct | Oct 4, 2011 (1d) |
| May 6, 2011 | BIIB | ↓ Sell | 967 | $96.13 | $93K | Direct | May 9, 2011 (3d) |
| May 4, 2011 | BIIB | ↓ Sell | 215 | $96.03 | $21K | Direct | May 4, 2011 (0d) |
| Mar 2, 2011 | BIIB | ↓ Sell | 1,402 | $70.02 | $98K | Direct | Mar 3, 2011 (1d) |
| Feb 24, 2011 | BIIB | ↓ Sell | 1,054 | $66.99 | $71K | Direct | Feb 25, 2011 (1d) |
| Feb 17, 2011 | BIIB | ↓ Sell | 732 | $67.10 | $49K | Direct | Feb 18, 2011 (1d) |
| Jan 4, 2011 | BIIB | ↓ Sell | 5,103 | $66.57 | $340K | Direct | Jan 5, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IRD insiders
Open-market trades in the last 12 months
About Robert E. Gagnon's insider trades
Robert E. Gagnon is Chief Financial Officer at Opus Genetics (IRD). Since Dec 6, 2010, Robert has reported 5 open-market purchases worth $94K and 46 sales worth $4.3M on SEC Form 4. In the last 12 months: 3 sales ($179K).
2 sales (5% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (31 filings), shares withheld for taxes (17 filings), option exercises (9 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.